ASRT Stock Summary and Trading Ideas (Assertio Hldgs | NASDAQ:ASRT)

Assertio Holdings Inc is a pharmaceutical company. It is engaged in comprehensive commercial capabilities, offering differentiated products designed to address patients' needs. Its focus is on supporting patients by marketing products mainly in the oncology market. The Company operates in the business within one reportable segment, relating to the sale of pharmaceutical products to its customers.

Assertio Hldgs trades on the NASDAQ stock market under the symbol ASRT.

As of June 10, 2026, ASRT stock price climbed to $23.48 with 316,254 million shares trading.

ASRT has a beta of -0.23, meaning it tends to be less sensitive to market movements. ASRT has a correlation of 0.00 to the broad based SPY ETF.

ASRT has a market cap of $151.73 million. This is considered a Micro Cap stock.

Last quarter Assertio Hldgs reported $10 million in Revenue and -$2.93 earnings per share. This beat revenue expectation by $692,600 and missed earnings estimates by -$1.42.

In the last 3 years, ASRT traded as high as $96.15 and as low as $7.71.

The top ETF exchange traded funds that ASRT belongs to (by Net Assets): VTI, VXF, AVSC.

ASRT has outperformed the market in the last year with a price return of +137.9% while the SPY ETF gained +22.8%. ASRT has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +102.9% and +0.1%, respectively, while the SPY returned +7.7% and -2.9%, respectively.

ASRT support price is $23.27 and resistance is $23.65 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ASRT shares will trade within this expected range on the day.